Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences

Type 2 leprosy reaction (T2LR), or Erythema Nodosum Leprosum (ENL), often poses a therapeutic challenge to clinicians and commonly requires long courses of steroids for control. While immunosuppressants are known to achieve control and lower steroid dependence in T2LR, the prospect of managing a sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Snigdha, Khurana, Ananta, B, Savitha, Sardana, Kabir, Agarwal, Aastha, Muddebihal, Aishwarya, Raina, Alok, Paliwal, Purnima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831392/
https://www.ncbi.nlm.nih.gov/pubmed/33326870
http://dx.doi.org/10.1016/j.ijid.2020.12.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831392/
https://www.ncbi.nlm.nih.gov/pubmed/33326870
http://dx.doi.org/10.1016/j.ijid.2020.12.024

Ejemplares similares